Is there a Rational Approach for Increasing Drug Specificity? Considerations on CNS Target Choice and Validation (2007)
- Authors:
- Autor USP: ULRICH, ALEXANDER HENNING - IQ
- Unidade: IQ
- DOI: 10.2174/157488907779561736
- Assunto: DOENÇAS NEURODEGENERATIVAS
- Language: Inglês
- Imprenta:
- Source:
- Título: Recent Patents on CNS Drug Discovery
- ISSN: 1574-8898
- Volume/Número/Paginação/Ano: v.2, n.1, p.37-46, 2007
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
RESENDE, Rodrigo Ribeiro e ULRICH, Henning e FARIA, Marcella. Is there a Rational Approach for Increasing Drug Specificity? Considerations on CNS Target Choice and Validation. Recent Patents on CNS Drug Discovery, v. 2, n. 1, p. 37-46, 2007Tradução . . Disponível em: https://doi.org/10.2174/157488907779561736. Acesso em: 19 jan. 2026. -
APA
Resende, R. R., Ulrich, H., & Faria, M. (2007). Is there a Rational Approach for Increasing Drug Specificity? Considerations on CNS Target Choice and Validation. Recent Patents on CNS Drug Discovery, 2( 1), 37-46. doi:10.2174/157488907779561736 -
NLM
Resende RR, Ulrich H, Faria M. Is there a Rational Approach for Increasing Drug Specificity? Considerations on CNS Target Choice and Validation [Internet]. Recent Patents on CNS Drug Discovery. 2007 ;2( 1): 37-46.[citado 2026 jan. 19 ] Available from: https://doi.org/10.2174/157488907779561736 -
Vancouver
Resende RR, Ulrich H, Faria M. Is there a Rational Approach for Increasing Drug Specificity? Considerations on CNS Target Choice and Validation [Internet]. Recent Patents on CNS Drug Discovery. 2007 ;2( 1): 37-46.[citado 2026 jan. 19 ] Available from: https://doi.org/10.2174/157488907779561736 - Aluminum-induced alterations of purinergic signalling in embryonic neural progenitor cells
- Anti-inflamatory effect of the P2X7 receptor antagonist, Brilliant Blue G, in an animal model of Parkinson's disease
- Optimization of SELEX: comparison of different methods for monitoring the progress of in vitro selection of aptamers
- Reverted effect of mesenchymal stem cells in glioblastoma treated with agathisflavone and its selective antitumoral effect on cell viability, migration, and differentiation via STAT3
- Immobilized P2'X IND. 2' purinergic receptor stationary phase for chromatographic determination of pharmaceological properties and drug screening
- Kinins and microglial responses in bipolar disorder: a neuroinflammation hypothesis
- Pharmacological properties of suramin as non-competitive antagonist of rat P2X2 receptor
- Characterization of RNA aptamers as specific inhibitors of P2X4 receptors
- 'P2X IND. 2' and 'P2Y IND. 2' purinergic receptor specific RNA interference to study their participation in neuronal differentiation
- Kinin-B2 receptor mediated neuroprotection after NMDA excitotoxicity is reversed in the presence of Kinin-B1 receptor agonists
Informações sobre o DOI: 10.2174/157488907779561736 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
